O'Shares Investment Advisers’s Bio-Techne TECH Stock Holding History

O'Shares Investment Advisers’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-8,880	Closed	-$961K	–	232
2022 Q1	$961K	Buy	8,880 +480	+6%	+$49.5K	0.08%	220
2021 Q4	$1.09M	Buy	8,400 +192	+2%	+$23.5K	0.08%	217
2021 Q3	$994K	Sell	8,208 -19,212	-70%	-$2.34M	0.07%	215
2021 Q2	$3.09M	Sell	27,420 -8,372	-23%	-$881K	0.22%	119
2021 Q1	$3.42M	Buy	35,792 +864	+2%	+$78.8K	0.25%	112
2020 Q4	$2.77M	Buy	34,928 +2,516	+8%	+$182K	0.21%	109
2020 Q3	$2.01M	Buy	32,412 +6,452	+25%	+$420K	0.21%	117
2020 Q2	$1.71M	Buy	+25,960	New	+$1.55M	0.22%	116

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

O'Shares Investment Advisers's TECH Position: Q2 2022 in Review

O'Shares Investment Advisers sold out of Bio-Techne (TECH) in Q2 2022, closing a stake of 8,880 shares — an estimated $961K sold.

O'Shares Investment Advisers first reported a position in TECH in Q2 2020 and held it in 8 quarters. The position peaked at $3.42M in Q1 2021. 549 funds tracked by Wall St. Rank hold TECH as of Q2 2022.

O'Shares Investment Advisers reported no remaining Bio-Techne position as of Q2 2022 after selling out during the quarter.
O'Shares Investment Advisers sold 8,880 Bio-Techne shares in Q2 2022, an estimated $961K.
O'Shares Investment Advisers first reported a position in Bio-Techne in Q2 2020 and held it in 8 quarters.
O'Shares Investment Advisers's Bio-Techne position peaked at $3.42M in Q1 2021.
549 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2022.

Based on O'Shares Investment Advisers's 13F filing for Q2 2022.